AXT INC (AXTI): Nasdaq/NYSE listing notice — AXT corrects 8-K to show Nasdaq notice date for audit committee non-compliance

AXT INC

Nasdaq notified AXT on July 18, 2025 that audit committee has only two independent directors after Christine Russell's passing.
Cure period: until earlier of next annual meeting or July 11, 2026; if annual meeting before Jan 7, 2026, evidence due by Jan 7, 2026.
Board plans to add a new independent director to regain compliance before cure period expires.
Non-compliance stems from Nasdaq Listing Rule 5605(c)(2)(A) requiring three independent audit committee members.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

AXT INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: audit committee
Rules: 5605(c)(2)(A), 5605(c)(4)

Exact text from the filing

July 18, 2025. Other than the correction of the date, no other changes have been made to the Initial Report. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing . (a) As previously, on July 14, 2025, AXT, Inc. (the “Company”) notified The Nasdaq Stock Market (“Nasdaq”) that as a result of the recent passing of Ms. Christine Russell, the Company is not compliant with Nasdaq Lising Rule 5605(c)(2)(A) as the Company’s Audit Committee currently consists of only two independent directors, rather than the minimum three independent directors a

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

AXT INC filing history →

Source: SEC EDGAR

accession 0001437749-25-023431

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.